drugset / Trial / NCT02496546

An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

NCT02496546 ↗

Phase 1 Completed 30 enrolled LEO Pharma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this trial is to assess the efficacy of LEO 32731 cream 20 mg/g compared with LEO 32731 cream vehicle in adults with mild to moderate AD after 3 weeks of treatment.

Timeline

Start
2015-07
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject LEO 32731 Unknown 20 unknown Topical

Indications